Newsroom

2006 Archive

Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

Friday, December 22, 2006
Bausch & Lomb’s Listing on New York Stock Exchange Extended
Thursday, December 21, 2006
Patients Refit With Bausch & Lomb’s PureVision® Toric Contact Lens Obtain Better Vision Compared to Leading Toric SiHy Lens
Wednesday, December 20, 2006
Alimera Sciences and Bausch & Lomb Announce Transaction For Alaway™ OTC Eye Care Product
Monday, December 04, 2006
Bausch & Lomb Expands PureVision® Toric Parameters
Monday, November 20, 2006
Bausch & Lomb Names Christopher Snyder Director of Professional Relations
Saturday, November 11, 2006
Bausch & Lomb Showcases New Technologies at AAO Annual Meeting
Thursday, November 09, 2006
Bausch & Lomb Reports Preliminary Third-Quarter and Year-to-Date 2006 Financial Metrics
Tuesday, November 07, 2006
Bausch & Lomb Declares Quarterly Dividend
Monday, November 06, 2006
Bausch & Lomb Receives FDA Warning Letter
Friday, September 29, 2006
Bausch & Lomb Obtains New York Stock Exchange Listing Extension
Wednesday, September 20, 2006
Bausch & Lomb To Adjust Worldwide Contact Lens Manufacturing Workforce
Tuesday, September 19, 2006
Bausch & Lomb Achieves Perfect Equality Score
Monday, September 18, 2006
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
Tuesday, August 29, 2006
Bausch & Lomb Licenses rPlasmin for Talecris Biotherapeutics for Ophthalmic Use
Tuesday, August 22, 2006
Bausch & Lomb Comments on Fusarium Keratitis Article
Tuesday, August 08, 2006
Bausch & Lomb Updates Status of Financial Reporting
Tuesday, July 25, 2006
Bausch & Lomb Declares Quarterly Dividend
Monday, June 05, 2006
Bausch & Lomb Announces Results of Tender Offer
Tuesday, May 30, 2006
Bausch & Lomb Receives Required Consents on Debt Issues
Wednesday, May 24, 2006
Bausch & Lomb Further Extends Consent Solicitation on 7.125% Debentures Due in 2028
Monday, May 22, 2006
Bausch & Lomb Expands Parameters for PureVision® Toric Contact Lens in U.S.
Monday, May 22, 2006
Bausch & Lomb Announces Results of Consent Solicitations on FourDebt Issues
Friday, May 19, 2006
Bausch & Lomb Further Extends Consent Solicitation Deadline with Respect to Tender Offers and Consent Solicitations for 7.125% Debentures Due 2028
Friday, May 19, 2006
Fusarium Keratitis & Bausch & Lomb's Response - An Issue Summary - May 19, 2006
Friday, May 19, 2006
CDC Report Supports Bausch & Lomb's Decision to Recall MoistureLoc® Solution, Only Product Associated with Unusual Increase in Fusarium Infections
Friday, May 19, 2006
Bausch & Lomb Receives IRS Notice of Administrative Adjustment for 1999 Tax Year
Wednesday, May 17, 2006
Bausch & Lomb Clarifies Reporting Of Fusarium Keratitis Cases to FDA
Wednesday, May 17, 2006
Bausch & Lomb Extends Consent Solicitation Deadline with Respect to Tender Offers and Consent Solicitations for 7.125% Debentures Due 2028
Tuesday, May 16, 2006
Bausch & Lomb Statement Regarding Its Greenville, S.C., Manufacturing Plant
Monday, May 15, 2006
Bausch & Lomb Voluntarily Recalls MoistureLoc® Worldwide - Customer Safety is Our Top Priority, Says CEO
Wednesday, May 03, 2006
Bausch & Lomb Responds to May 2 CDC Release of Preliminary Data on Fusarium Keratitis Cases
Wednesday, May 03, 2006
Bausch & Lomb Announces Intention to Commence Tender Offers and Consent Solicitations on Debt Instruments
Tuesday, May 02, 2006
Bausch & Lomb Declares Quarterly Dividend
Thursday, April 20, 2006
Bausch & Lomb Named Tops in Diversity for Third Straight Year
Wednesday, April 19, 2006
Bausch & Lomb Names Dwain Hahs President of Asia Region
Thursday, April 13, 2006
Bausch & Lomb Asks Retailers to Remove U.S.-Manufactured ReNu® with MoistureLoc® from Shelves and Recommends Consumers Switch to Another Solution Pending Investigation of Reports of Fusarium Infections Among Contact Lens Wearers
Tuesday, April 11, 2006
Bausch & Lomb Schedules Conference Call to Update Investors on ReNu® with MoistureLoc® Situation
Monday, April 10, 2006
Bausch & Lomb Temporarily Suspends U.S. Shipments of ReNu® with MoistureLoc® Produced at Greenville, S.C., Manufacturing Facility Pending Investigation of Reports of Fusarium Infections Among Contact Lens Wearers
Monday, April 10, 2006
Bausch & Lomb Provides Information Regarding U.S. Sales of ReNu® with MoistureLoc® Solution
Friday, April 07, 2006
Bausch & Lomb Reminds Contact Lens Wearers Of Importance of Proper Lens Care
Friday, March 31, 2006
Bausch & Lomb Collaborates with Experts to Investigate Extent and Cause of Fungal Eye Infections
Monday, March 20, 2006
FDA Approves Bausch & Lomb's 100 Hertz Zyoptix™ Excimer Laser
Friday, March 17, 2006
Bausch & Lomb Updates Status of Financial Reporting
Tuesday, February 28, 2006
Bausch & Lomb Declares Quarterly Dividend
Tuesday, February 28, 2006
Dr. Joseph Salamone Elected Fellow, American Institute for Medical and Biological Engineering
Thursday, February 23, 2006
Bausch & Lomb Launching PureVision® Multi-Focal Contact Lens in U.S. First to Offer Full Range of Silicone Hydrogel Lenses in Spherical, Toric & Multifocal Designs
Thursday, February 23, 2006
Bausch & Lomb GP Materials Receive Expanded FDA Post-Surgical Indications
Thursday, February 09, 2006
Bausch & Lomb Teams with Novartis Ophthalmics To Co-Promote Bausch & Lomb Retisert™
Thursday, January 26, 2006
Bausch & Lomb Expects to Report Preliminary Fourth Quarter and Full Year 2005 Results in Early March
Thursday, January 05, 2006
Bausch & Lomb to Present at Two Investor Conferences